Condition 1: leukemia. Condition 2: leukemia. Condition 3: leukemia. Lymphoid leukaemia Multiple myeloma and malignant plasma cell neoplasms Myeloid leukaemia
Conditions
Interventions
Intervention 1: "Intervention group": The intervention group participates in 4 sessions of 2 hours (weekly one session), which is provided by the researcher in lecture, question and answer, and provid
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult patients (18 years and older) who have leukemia tend to participate in the study Six months from the definitive diagnosis of the disease.
Exclusion criteria
Exclusion criteria: Have a history of attending classes on self-efficacy and quality of life. Classes have more than one absentee session. Patients discontinue the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life and self-efficacy. Timepoint: Immediately and a month later. Method of measurement: Quality of life questionnaire and self-efficacy. | — |
Secondary
| Measure | Time frame |
|---|---|
| Knowledge. Timepoint: Immediately and 1 months later. Method of measurement: Pender Model Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFariba Ghodsbin
Shiraz University of Medical Sciences
Outcome results
None listed